Logo image of BTSGU

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 (BTSGU) Stock Fundamental Analysis

NASDAQ:BTSGU - Nasdaq - US10950A2050

73.87  +6.68 (+9.94%)

Fundamental Rating

4

Overall BTSGU gets a fundamental rating of 4 out of 10. We evaluated BTSGU against 108 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of BTSGU have multiple concerns. BTSGU is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BTSGU was profitable.
BTSGU had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BTSGU reported negative net income in multiple years.
Of the past 5 years BTSGU 4 years had a positive operating cash flow.
BTSGU Yearly Net Income VS EBIT VS OCF VS FCFBTSGU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

1.2 Ratios

BTSGU has a Return On Assets of -0.70%. This is comparable to the rest of the industry: BTSGU outperforms 52.34% of its industry peers.
BTSGU has a Return On Equity of -2.51%. This is comparable to the rest of the industry: BTSGU outperforms 54.21% of its industry peers.
BTSGU has a Return On Invested Capital (3.42%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for BTSGU is below the industry average of 8.27%.
Industry RankSector Rank
ROA -0.7%
ROE -2.51%
ROIC 3.42%
ROA(3y)-0.96%
ROA(5y)-0.86%
ROE(3y)-9.05%
ROE(5y)-7.04%
ROIC(3y)3.57%
ROIC(5y)3.15%
BTSGU Yearly ROA, ROE, ROICBTSGU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

BTSGU has a Operating Margin (1.85%) which is in line with its industry peers.
BTSGU's Operating Margin has declined in the last couple of years.
The Gross Margin of BTSGU (14.50%) is worse than 72.90% of its industry peers.
In the last couple of years the Gross Margin of BTSGU has grown nicely.
Industry RankSector Rank
OM 1.85%
PM (TTM) N/A
GM 14.5%
OM growth 3Y-17.41%
OM growth 5Y-7.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.85%
BTSGU Yearly Profit, Operating, Gross MarginsBTSGU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 5 10 15

3

2. Health

2.1 Basic Checks

BTSGU has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BTSGU has been reduced compared to 1 year ago.
BTSGU has a better debt/assets ratio than last year.
BTSGU Yearly Shares OutstandingBTSGU Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M
BTSGU Yearly Total Debt VS Total AssetsBTSGU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

BTSGU has an Altman-Z score of 3.66. This indicates that BTSGU is financially healthy and has little risk of bankruptcy at the moment.
BTSGU has a Altman-Z score of 3.66. This is in the better half of the industry: BTSGU outperforms 74.77% of its industry peers.
BTSGU has a debt to FCF ratio of 205.30. This is a negative value and a sign of low solvency as BTSGU would need 205.30 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 205.30, BTSGU is in line with its industry, outperforming 46.73% of the companies in the same industry.
A Debt/Equity ratio of 1.63 is on the high side and indicates that BTSGU has dependencies on debt financing.
BTSGU has a Debt to Equity ratio of 1.63. This is in the lower half of the industry: BTSGU underperforms 74.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF 205.3
Altman-Z 3.66
ROIC/WACC0.39
WACC8.78%
BTSGU Yearly LT Debt VS Equity VS FCFBTSGU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

2.3 Liquidity

BTSGU has a Current Ratio of 1.35. This is a normal value and indicates that BTSGU is financially healthy and should not expect problems in meeting its short term obligations.
BTSGU has a Current ratio (1.35) which is in line with its industry peers.
A Quick Ratio of 0.97 indicates that BTSGU may have some problems paying its short term obligations.
BTSGU has a Quick ratio of 0.97. This is in the lower half of the industry: BTSGU underperforms 72.90% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.97
BTSGU Yearly Current Assets VS Current LiabilitesBTSGU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 500M 1B

6

3. Growth

3.1 Past

BTSGU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -322.58%.
The Revenue has grown by 14.32% in the past year. This is quite good.
BTSGU shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.33% yearly.
EPS 1Y (TTM)-322.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.54%
Revenue 1Y (TTM)14.32%
Revenue growth 3Y16.51%
Revenue growth 5Y28.33%
Sales Q2Q%28.82%

3.2 Future

The Earnings Per Share is expected to grow by 43.10% on average over the next years. This is a very strong growth
BTSGU is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.54% yearly.
EPS Next Y245.1%
EPS Next 2Y101.15%
EPS Next 3Y62.89%
EPS Next 5Y43.1%
Revenue Next Year26.77%
Revenue Next 2Y18.54%
Revenue Next 3Y15.31%
Revenue Next 5Y11.54%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BTSGU Yearly Revenue VS EstimatesBTSGU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
BTSGU Yearly EPS VS EstimatesBTSGU Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 157.17, which means the current valuation is very expensive for BTSGU.
BTSGU's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 28.29. BTSGU is valued rather expensively when compared to this.
BTSGU is valuated quite expensively with a Price/Forward Earnings ratio of 88.48.
BTSGU's Price/Forward Earnings ratio is in line with the industry average.
BTSGU is valuated expensively when we compare the Price/Forward Earnings ratio to 24.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 157.17
Fwd PE 88.48
BTSGU Price Earnings VS Forward Price EarningsBTSGU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

BTSGU's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BTSGU is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 979.96
EV/EBITDA 36.24
BTSGU Per share dataBTSGU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

BTSGU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BTSGU's earnings are expected to grow with 62.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.64
PEG (5Y)N/A
EPS Next 2Y101.15%
EPS Next 3Y62.89%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.77%, BTSGU has a reasonable but not impressive dividend return.
BTSGU's Dividend Yield is rather good when compared to the industry average which is at 2.87. BTSGU pays more dividend than 96.26% of the companies in the same industry.
BTSGU's Dividend Yield is rather good when compared to the S&P500 average which is at 2.28.
Industry RankSector Rank
Dividend Yield 3.77%

5.2 History

BTSGU does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BTSGU Yearly Dividends per shareBTSGU Yearly Dividends per shareYearly Dividends per share 2024 2025 0.5 1 1.5

5.3 Sustainability

DPN/A
EPS Next 2Y101.15%
EPS Next 3Y62.89%
BTSGU Yearly Income VS Free CF VS DividendBTSGU Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27

NASDAQ:BTSGU (1/21/2025, 4:30:01 PM)

73.87

+6.68 (+9.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-01 2024-11-01/bmo
Earnings (Next)N/A N/A
Inst Owners47.01%
Inst Owner ChangeN/A
Ins Owners0.64%
Ins Owner ChangeN/A
Market Cap12.86B
Analysts84.21
Price Target83.63 (13.21%)
Short Float %0.01%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield 3.77%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date01-15 2025-01-15 (0.8438)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-39.48%
Min EPS beat(2)-40.94%
Max EPS beat(2)-38.02%
EPS beat(4)2
Avg EPS beat(4)11.75%
Min EPS beat(4)-40.94%
Max EPS beat(4)77.58%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.62%
Min Revenue beat(2)2.41%
Max Revenue beat(2)4.83%
Revenue beat(4)3
Avg Revenue beat(4)3.75%
Min Revenue beat(4)-1.47%
Max Revenue beat(4)9.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.93%
PT rev (3m)35.69%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.04%
EPS NY rev (1m)0%
EPS NY rev (3m)-22.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.3%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.27%
Valuation
Industry RankSector Rank
PE 157.17
Fwd PE 88.48
P/S 1.21
P/FCF 979.96
P/OCF 134.6
P/B 7.97
P/tB N/A
EV/EBITDA 36.24
EPS(TTM)0.47
EY0.64%
EPS(NY)0.83
Fwd EY1.13%
FCF(TTM)0.08
FCFY0.1%
OCF(TTM)0.55
OCFY0.74%
SpS60.81
BVpS9.27
TBVpS-10.91
PEG (NY)0.64
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.7%
ROE -2.51%
ROCE 4.33%
ROIC 3.42%
ROICexc 3.44%
ROICexgc 15.92%
OM 1.85%
PM (TTM) N/A
GM 14.5%
FCFM 0.12%
ROA(3y)-0.96%
ROA(5y)-0.86%
ROE(3y)-9.05%
ROE(5y)-7.04%
ROIC(3y)3.57%
ROIC(5y)3.15%
ROICexc(3y)3.6%
ROICexc(5y)3.21%
ROICexgc(3y)19.01%
ROICexgc(5y)16.22%
ROCE(3y)4.53%
ROCE(5y)3.98%
ROICexcg growth 3Y-4.2%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.64%
ROICexc growth 5YN/A
OM growth 3Y-17.41%
OM growth 5Y-7.89%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.74%
GM growth 5Y1.85%
F-Score6
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 1.63
Debt/FCF 205.3
Debt/EBITDA 6.65
Cap/Depr 41.09%
Cap/Sales 0.78%
Interest Coverage 0.81
Cash Conversion 24.12%
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 0.97
Altman-Z 3.66
F-Score6
WACC8.78%
ROIC/WACC0.39
Cap/Depr(3y)33.49%
Cap/Depr(5y)32.43%
Cap/Sales(3y)0.88%
Cap/Sales(5y)0.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-322.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.54%
EPS Next Y245.1%
EPS Next 2Y101.15%
EPS Next 3Y62.89%
EPS Next 5Y43.1%
Revenue 1Y (TTM)14.32%
Revenue growth 3Y16.51%
Revenue growth 5Y28.33%
Sales Q2Q%28.82%
Revenue Next Year26.77%
Revenue Next 2Y18.54%
Revenue Next 3Y15.31%
Revenue Next 5Y11.54%
EBIT growth 1Y-35.64%
EBIT growth 3Y-3.78%
EBIT growth 5Y18.2%
EBIT Next Year74.21%
EBIT Next 3Y27.14%
EBIT Next 5YN/A
FCF growth 1Y477.48%
FCF growth 3Y-7.02%
FCF growth 5Y25.98%
OCF growth 1Y34.3%
OCF growth 3Y-1.81%
OCF growth 5Y22.49%